Superior immunogenicity of seasonal influenza vaccines containing full dose of MF59®adjuvant
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Superior immunogenicity of seasonal influenza vaccines containing full dose of MF59®adjuvant
Authors
Keywords
-
Journal
Human Vaccines & Immunotherapeutics
Volume 8, Issue 2, Pages 216-227
Publisher
Informa UK Limited
Online
2012-04-06
DOI
10.4161/hv.18445
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Healthy Human Subjects Have CD4+ T Cells Directed against H5N1 Influenza Virus
- (2014) M. Roti et al. JOURNAL OF IMMUNOLOGY
- MF59 adjuvant: the best insurance against influenza strain diversity
- (2011) Derek T O’Hagan et al. Expert Review of Vaccines
- Assessment of the safety, tolerability and kinetics of the immune response to A/H1N1v vaccine formulations with and without adjuvant in healthy pediatric subjects from 3 through 17 years of age
- (2011) Adriano Arguedas et al. Human vaccines & immunotherapeutics
- Antigen-stimulated CD4 T-cell expansion is inversely and log-linearly related to precursor number
- (2011) J. Quiel et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Feedback regulation of proliferation vs. differentiation rates explains the dependence of CD4 T-cell expansion on precursor number
- (2011) G. Bocharov et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Influenza vaccine immunology
- (2010) Philip R. Dormitzer et al. IMMUNOLOGICAL REVIEWS
- The need for quadrivalent vaccine against seasonal influenza
- (2010) Robert B. Belshe VACCINE
- In Vitro Responses to Avian Influenza H5 by Human CD4 T Cells
- (2009) M. F. Cusick et al. JOURNAL OF IMMUNOLOGY
- Randomized, Double‐Blind Controlled Phase 3 Trial Comparing the Immunogenicity of High‐Dose and Standard‐Dose Influenza Vaccine in Adults 65 Years of Age and Older
- (2009) Ann R. Falsey et al. JOURNAL OF INFECTIOUS DISEASES
- Enhanced Immunogenicity of Seasonal Influenza Vaccines in Young Children Using MF59 Adjuvant
- (2009) Timo Vesikari et al. PEDIATRIC INFECTIOUS DISEASE JOURNAL
- MF59®-Adjuvanted H5N1 Vaccine Induces Immunologic Memory and Heterotypic Antibody Responses in Non-Elderly and Elderly Adults
- (2009) Angelika Banzhoff et al. PLoS One
- Adjuvanted H5N1 vaccine induces early CD4+ T cell response that predicts long-term persistence of protective antibody levels
- (2009) G. Galli et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Granzyme B: Correlates with protection and enhanced CTL response to influenza vaccination in older adults
- (2009) Janet E. McElhaney et al. VACCINE
- MF59-adjuvanted versus non-adjuvanted influenza vaccines: Integrated analysis from a large safety database
- (2009) Michele Pellegrini et al. VACCINE
- Dose ranging of adjuvant and antigen in a cell culture H5N1 influenza vaccine: Safety and immunogenicity of a phase 1/2 clinical trial
- (2009) Wendy Keitel et al. VACCINE
- Emerging vaccines for influenza
- (2008) Pritish K Tosh et al. EXPERT OPINION ON EMERGING DRUGS
- Intradermal Influenza Vaccine Administered Using a New Microinjection System Produces Superior Immunogenicity in Elderly Adults: A Randomized Controlled Trial
- (2008) David Holland et al. JOURNAL OF INFECTIOUS DISEASES
- Safety and immunogenicity of an MF59™-adjuvanted subunit influenza vaccine in elderly Chinese subjects
- (2008) Rongcheng Li et al. Immunity & Ageing
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started